About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Alendronate Sodium
- Company
- Odense University Hospital
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 7 recruiting
Efficacy results: Not yet reported
7 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026
Find a Clinical Trial Near Me
See recruiting studies for Alendronate Sodium and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT04704947
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
Not yet reported Sherief Abd-Elsalam 50 participants Est. completion 2030-10-01 1 site Stand-aloneOther conditions: Beta Blocker ToxicityView official trial listing → -
Recruiting NCT NCT05527548
A Multi-centre, Double-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR
Not yet reported Chinese University of Hong Kong 100 participants Est. completion 2028-07-22 1 site Stand-aloneOther conditions: ACL ReconstructionView official trial listing → -
Recruiting NCT NCT05764733
Bone, Exercise, Alendronate, and Caloric Restriction
Not yet reported Wake Forest University Health Sciences 900 participants Est. completion 2028-01 2 sites Stand-aloneOther conditions: Bone LossView official trial listing → -
Recruiting NCT NCT06016634
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Not yet reported University of California, Davis 30 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis, Ischemic Necrosis, Avascular NecrosisView official trial listing → -
Recruiting NCT NCT06864130
A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
Not yet reported Odense University Hospital 1400 participants Est. completion 2029-09-15 8 sites Stand-aloneOther conditions: Osteoporosis in Post-menopausal WomenView official trial listing → -
Recruiting NCT NCT07216794
Small Trial of Alendronate Impact on the Reservoir of HIV
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 2027-05-21 5 sites Stand-aloneOther conditions: HIVView official trial listing → -
Recruiting NCT NCT07435051
Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 280 participants Est. completion 2030-12-31 1 site Stand-aloneOther conditions: Osteomyelitis (Refractory)View official trial listing → -
Completed NCT NCT00000400
Alendronate and/or Parathyroid Hormone for Osteoporosis
Not yet reported Massachusetts General Hospital 176 participants Est. completion 2006-06 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00000412
Osteoporosis Prevention After Heart Transplant
Not yet reported Columbia University 149 participants Est. completion 2002-04 2 sitesOther conditions: Osteoporosis, Cardiac TransplantationView official trial listing → -
Completed NCT NCT00000427
Effects of Parathyroid Hormone in Men With Osteoporosis
Not yet reported Massachusetts General Hospital 81 participants Est. completion 2005-10 1 siteOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00000430
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 240 participants Est. completion 2004-09 1 siteOther conditions: Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00001720
Treatment of Childhood Osteoporosis With Alendronate (Fosamax)
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50 participants Est. completion 2003-06 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00001728
Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 40 participants Est. completion 2011-05-02 1 siteOther conditions: Polyostotic Fibrous DysplasiaView official trial listing → -
Completed NCT NCT00004488
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
Not yet reported Children's Hospital Medical Center, Cincinnati 82 participants Est. completion 2002-09 3 sitesOther conditions: Gaucher's Disease, OsteopeniaView official trial listing → -
Completed NCT NCT00004489
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Not yet reported University of North Carolina 60 participants Est. completion 2002-09 1 siteOther conditions: Osteoporosis, Cystic FibrosisView official trial listing → -
Completed NCT NCT00005005
PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
Not yet reported Dennis Black 238 participants Est. completion 2007-11 4 sites Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00005006
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Not yet reported Helen Hayes Hospital 140 participants Est. completion 2006-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00006180
Bone Loss in Premenopausal Women With Depression
Not yet reported National Institute of Mental Health (NIMH) 220 participants Est. completion 2007-01-19 1 siteOther conditions: Depression, Healthy, Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00010439
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Not yet reported Medical University of South Carolina 10 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00019695
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Not yet reported National Cancer Institute (NCI) Est. completion 2005-03 1 siteOther conditions: Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate, Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT00035971
EVA: Evista Alendronate Comparison
Not yet reported Eli Lilly and Company 86 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00043186
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
Not yet reported Amgen 412 participants Est. completion 2007-06Other conditions: Low Bone Mineral DensityView official trial listing → -
Completed NCT NCT00048841
Prevention of Osteoporosis in Men With Prostate Cancer
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112 participants Est. completion 2005-12 1 siteOther conditions: Prostate Cancer, Osteoporosis, HypogonadismView official trial listing → -
Completed NCT NCT00051558
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
Not yet reported Eli Lilly and Company 428 participants Est. completion 2008-01 15 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00061256
The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 80 participants Est. completion 2006-09 28 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00079924
Effects of Teriparatide in Postmenopausal Women With Osteoporosis
Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-05 10 sitesOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00092014
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
Not yet reported Organon and Co 1053 participants Est. completion 2004-04-01 Stand-aloneOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00092027
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
Not yet reported Organon and Co 454 participants Est. completion 2004-03-15Other conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00092040
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
Not yet reported Organon and Co 936 participants Est. completion 2005-09-28Other conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00092066
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
Not yet reported Organon and Co 717 participants Est. completion 2004-05-01Other conditions: Osteoporosis, Vitamin D DeficiencyView official trial listing → -
Completed NCT NCT00092079
A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
Not yet reported Merck Sharp & Dohme LLC 652 participants Est. completion 2004-11Other conditions: Osteoporosis, Vitamin D DeficiencyView official trial listing → -
Completed NCT NCT00120757
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)
Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 140 participants Est. completion 2008-11 3 sitesOther conditions: Osteoporosis, HIV InfectionsView official trial listing → -
Completed NCT NCT00122356
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
Not yet reported Barwon Health 303 participants Est. completion 2013-03 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00130403
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Not yet reported Sanofi 290 participants Est. completion 2007-03 7 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00136058
Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
Not yet reported University of Alberta 250 participants Est. completion 2006-04 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00138983
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
Not yet reported UMC Utrecht 200 participants Est. completion 2003-11 1 siteOther conditions: Rheumatoid Arthritis, Polymyalgia Rheumatica, Giant Cell Arteritis, Polymyositis, Wegener's GranulomatosisView official trial listing → -
Completed NCT NCT00145977
Texture Analysis for Postmenopausal Osteoporosis
Not yet reported University of Chicago 36 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Osteoporosis, OsteopeniaView official trial listing → -
Completed NCT NCT00157690
Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
Not yet reported McMaster University 56 participants Est. completion 2006-08 6 sitesOther conditions: Cystic Fibrosis, Osteoporosis, Bone Diseases, MetabolicView official trial listing → -
Completed NCT NCT00159419
Bisphosphonate Therapy for Osteogenesis Imperfecta
Not yet reported Indiana University 18 participants Est. completion 2008-08Other conditions: Osteogenesis Imperfecta, Osteoporosis, Paget Disease of BoneView official trial listing → -
Completed NCT NCT00168909
Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
Not yet reported Charite University, Berlin, Germany 282 participants Est. completion 2008-05 2 sitesOther conditions: Osteoporosis, Postmenopausal, Osteopenia, FallsView official trial listing → -
Completed NCT NCT00177619
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
Not yet reported University of Pittsburgh 120 participants Est. completion 2005-12 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00191893
Bone Effects of Teriparatide Following Alendronate
Not yet reported Eli Lilly and Company 66 participants Est. completion 2006-11 2 sitesOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT00209469
Network Osteoporosis Study
Not yet reported, Not yet reported Glaser Pediatric Research Network 90 participants Est. completion 2007-02 4 sitesOther conditions: Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00221312
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
University of California, San Francisco 48 participants Est. completion 2007-07 1 siteOther conditions: Perimenopausal Bone LossView official trial listing → -
Terminated NCT NCT00236002
Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
Not yet reported Canadian Urology Research Consortium 182 participants Est. completion 2009-08Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00259857
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Not yet reported Medical University of South Carolina 22 participants Est. completion 2009-08 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00261625
Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
Not yet reported National Taiwan University Hospital 50 participants Est. completion 2007-10Other conditions: End-Stage Renal Disease, OsteoporosisView official trial listing → -
Status unknown NCT NCT00265252
Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 60 participants Est. completion 2008-06 1 siteOther conditions: Non-Traumatic OsteonecrosisView official trial listing → -
Completed NCT NCT00277251
Alendronate Osteoporosis Study
Not yet reported, Not yet reported Boston Children's Hospital 20 participants Est. completion 2006-06Other conditions: Glucocorticoid-Associated Osteopenia and OsteoporosisView official trial listing → -
Completed NCT NCT00293813
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
Not yet reported Amgen 247 participants Est. completion 2008-08 Stand-aloneOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00297830
Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation
Not yet reported, Not yet reported Columbia University 111 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Heart Transplantation, Liver Transplantation, Bone ResorptionView official trial listing → -
Status unknown NCT NCT00299572
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Not yet reported Far Eastern Memorial Hospital 50 participants Est. completion 2006-12 1 siteOther conditions: Peritoneal DialysisView official trial listing → -
Completed NCT NCT00327990
Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
Not yet reported GlaxoSmithKline 300 participants Est. completion 2006-12 38 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00330460
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
Not yet reported Amgen 1189 participants Est. completion 2008-01Other conditions: Osteoporosis, OsteopeniaView official trial listing → -
Status unknown NCT NCT00346190
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 10 participants Est. completion 2007-04 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00354302
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
Not yet reported NCIC Clinical Trials Group 497 participants Est. completion 2012-01-06 13 sitesOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Withdrawn NCT NCT00359385
The Effects of Alendronate After Cure of Primary Hyperparathyroidism
Not yet reported Columbia University Est. completion 2009-09 1 siteOther conditions: HyperparathyroidismView official trial listing → -
Completed NCT NCT00377819
Study of Transitioning From Alendronate to Denosumab
Not yet reported Amgen 504 participants Est. completion 2008-07Other conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00389740
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
Not yet reported Organon and Co 400 participants Est. completion 2003-01-16Other conditions: Osteoporosis, PostmenopausalView official trial listing → -
Status unknown NCT NCT00391404
Fosamax for Childhood Cancer Survivors
Not yet reported Chinese University of Hong Kong 100 participants Est. completion 2008-10 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00395382
Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
Not yet reported Monash University 50 participants Est. completion 2009-09 1 siteOther conditions: Vascular Calcification, ArteriosclerosisView official trial listing → -
Completed NCT NCT00398606
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
Not yet reported Organon and Co 650 participantsOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00398931
FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)
Not yet reported Organon and Co 1099 participants Est. completion 2003-10Other conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00400530
Upper GI Handling of Branded vs. Generic Alendronate
Not yet reported Merck Sharp & Dohme LLC 25 participantsOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00404820
Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis
Not yet reported Novartis 604 participants Est. completion 2008-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00421343
Secondary Prevention of Osteoporosis
Not yet reported Hebrew SeniorLife 29 participants Est. completion 2008-06 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00460057
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
Not yet reported Eulji University Hospital 63 participants Est. completion 2007-02Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00463268
Osteoporosis Prevention With Low Dose Alendronate
Not yet reported University Hospital of Mont-Godinne 83 participants Est. completion 2012-01 1 siteOther conditions: OsteopeniaView official trial listing → -
Terminated NCT NCT00471237
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Not yet reported GlaxoSmithKline 564 participants Est. completion 2008-12-26 49 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00480662
A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
Not yet reported Organon and Co 60 participants Est. completion 2002-10Other conditions: Paget's Disease of BoneView official trial listing → -
Completed NCT NCT00480766
A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)
Not yet reported Organon and Co 173 participants Est. completion 2003-08Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00503113
A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
Not yet reported Hoffmann-La Roche 801 participants Est. completion 2010-04 44 sitesOther conditions: Post-Menopausal OsteoporosisView official trial listing → -
Completed NCT NCT00504166
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
Not yet reported University of California, San Francisco 53 participants Est. completion 2009-04 1 siteOther conditions: Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00518531
Denosumab Adherence Preference Satisfaction Study
Not yet reported Amgen 250 participants Est. completion 2010-06-01Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00532337
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
Not yet reported Ono Pharma USA Inc 285 participants 1 siteOther conditions: Osteoporosis, OsteopeniaView official trial listing → -
Completed NCT NCT00545779
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Not yet reported Hoffmann-La Roche 677 participants Est. completion 2008-10 32 sitesOther conditions: Post-Menopausal OsteoporosisView official trial listing → -
Terminated NCT NCT00572299
Glucocorticoids Promote Osteoclast Survival
University of Arkansas 3 participants Est. completion 2010-05 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00577850
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Not yet reported Warner Chilcott 32 participants Est. completion 2004-02 2 sitesOther conditions: Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00580047
Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
Not yet reported University of Nebraska 59 participants Est. completion 2014-07-29 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Completed NCT NCT00593580
Bone Health in Gynecologic Cancers-does FOSAVANCE Help?
Not yet reported British Columbia Cancer Agency 60 participants Est. completion 2011-06 1 siteOther conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT00601068
Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis
University of Florida 35 participants Est. completion 2011-07 1 siteOther conditions: OsteonecrosisView official trial listing → -
Completed NCT NCT00641771
4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)
Not yet reported Organon and Co 56 participants Est. completion 2005-08 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00666627
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 410 participants Est. completion 2014-12 1 siteOther conditions: Post-menopausal OsteoporosisView official trial listing → -
Status unknown NCT NCT00668941
Cyclic Versus Daily Teriparatide on Bone Mass
Not yet reported Helen Hayes Hospital 140 participants Est. completion 2017-11 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00680953
Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
Not yet reported Daiichi Sankyo Co., Ltd. 1262 participants Est. completion 2012-07 4 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00692913
A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
Not yet reported Organon and Co 515 participants Est. completion 2010-07 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00713258
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
Not yet reported Nycomed 75 participants Est. completion 2010-09 1 siteOther conditions: Back PainView official trial listing → -
Status unknown NCT NCT00727493
Osteoporosis and Dental Implant
Not yet reported Charite University, Berlin, Germany 45 participants Est. completion 2010-04 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00729651
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
Not yet reported Organon and Co 343 participants Est. completion 2009-04-10 Stand-aloneOther conditions: Osteoporosis PostmenopausalView official trial listing → -
Completed NCT NCT00739466
Biorest Liposomal Alendronate With Stenting sTudy (BLAST)
Not yet reported BIOrest Ltd. 226 participants Est. completion 2015-12 12 sites Stand-aloneOther conditions: Coronary Artery StenosisView official trial listing → -
Completed NCT NCT00778154
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
Warner Chilcott 105 participants Est. completion 2006-12 8 sitesOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00803790
A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)
Not yet reported Organon and Co 318 participants Est. completion 2006-07 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00806416
A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D
Not yet reported Organon and Co 244 participants Est. completion 2004-01 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00822029
Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy
Not yet reported Department of Clinical Research and Innovation 2 participants Est. completion 2011-02 1 siteOther conditions: Osteoporosis, Cerebral PalsyView official trial listing → -
Completed NCT NCT00835406
Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
Not yet reported Teva Pharmaceuticals USA 140 participants Est. completion 2000-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00885170
A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)
Not yet reported Merck Sharp & Dohme LLC 246 participants Est. completion 2011-09-15Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00891553
CR9112792, a Follow-up of Study CR9108963
GlaxoSmithKline 171 participants Est. completion 2009-06 3 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00896532
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Not yet reported Amgen 419 participants Est. completion 2016-02-18Other conditions: Low Bone Mineral Density, Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT00919711
Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy
Not yet reported Amgen 870 participants Est. completion 2012-03-05Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00920075
Alendronate in Juvenile Osteoporosis
Medical University of South Carolina 11 participants Est. completion 2010-10 1 siteOther conditions: Juvenile Osteoporosis, Low Bone Density, FracturesView official trial listing → -
Completed NCT NCT00921557
Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2017-01 10 sites Stand-aloneOther conditions: HIV InfectionView official trial listing → -
Completed NCT NCT00936260
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Not yet reported Ciudad Universitaria, Spain 228 participants Est. completion 2004-12 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00983996
Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)
Not yet reported Mylan Pharmaceuticals Inc 112 participants Est. completion 2002-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00996801
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
Not yet reported Merck Sharp & Dohme LLC 526 participants Est. completion 2011-06 Stand-aloneOther conditions: Osteoporosis, Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT01012934
Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
Not yet reported Mylan Pharmaceuticals Inc 110 participants Est. completion 2002-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01020253
The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)
Not yet reported Yokohama City University Medical Center 60 participants 1 siteOther conditions: Bone Density, Arthroplasty, Replacement, HipView official trial listing → -
Completed NCT NCT01065779
FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)
Organon and Co 880 participants Est. completion 2010-07Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Organon and Co 684815 participants Est. completion 2012-02-16Other conditions: Esophageal Cancer, Squamous Cell Carcinoma, AdenocarcinomaView official trial listing → -
Completed NCT NCT01101048
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Not yet reported Amgen 74 participants Est. completion 2012-02Other conditions: OsteopeniaView official trial listing → -
Completed NCT NCT01104987
Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS)
Göteborg University 16 participants Est. completion 2016-07 1 siteOther conditions: Ankylosing Spondylitis, OsteoporosisView official trial listing → -
Completed NCT NCT01128257
A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis
Hoffmann-La Roche 6054 participants Est. completion 2011-12 1 siteOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Terminated NCT NCT01131884
Pilot Study of Fosamax in Spinal Cord Injury
Not yet reported University of Rochester 1 participants Est. completion 2012-12 2 sitesOther conditions: Spinal Cord Injury, OsteoporosisView official trial listing → -
Completed NCT NCT01133496
Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited, India 80 participants Est. completion 2007-04 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01265615
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
Not yet reported Ural State Medical University 109 participants Est. completion 2010-09 2 sitesOther conditions: Cardiorenal Syndrome, Chronic Allograft NephropathyView official trial listing → -
Completed NCT NCT01350934
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
Not yet reported Organon and Co 219 participants Est. completion 2013-01-10 Stand-aloneOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT01406613
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
Sheffield Teaching Hospitals NHS Foundation Trust 86 participants Est. completion 2015-11 1 siteOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT01415050
Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women
Not yet reported X-pert Med GmbH 80 participants Est. completion 2011-07 5 sitesOther conditions: Osteoporosis in Post-menopausal WomenView official trial listing → -
Completed NCT NCT01437111
Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)
Not yet reported Organon and Co 200 participants Est. completion 2012-12-05 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT01460654
Testosterone and Alendronate in Hypogonadal Men
Not yet reported Massachusetts General Hospital 44 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Hypogonadism, Osteopenia, OsteoporosisView official trial listing → -
Terminated NCT NCT01512446
Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Not yet reported Evangelisches Krankenhaus Lutherhaus gGmbH 436 participants Est. completion 2013-03 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01526278
Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women
Not yet reported Yuyu Pharma, Inc. 18 participants Est. completion 2012-09 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01535027
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
Not yet reported Medical University of Vienna 125 participants Est. completion 2012-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Withdrawn NCT NCT01552122
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
Not yet reported Merck Sharp & Dohme LLC Est. completion 2015-02 Stand-aloneOther conditions: Osteoporosis, Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT01588509
Transition From Alendronate to Romosozumab (AMG 785)
Not yet reported Amgen 60 participants Est. completion 2012-11-21 9 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01631214
Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Not yet reported Amgen 4093 participants Est. completion 2017-06-29 316 sites Stand-aloneOther conditions: Postmenopausal Women With OsteoporosisView official trial listing → -
Completed NCT NCT01648686
Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly
Not yet reported Assistance Publique - Hôpitaux de Paris 66 participants Est. completion 2015-11-05 1 siteOther conditions: Alveolar Bone Healing After Dental ExtractionView official trial listing → -
Terminated NCT NCT01656629
Stem Cell Recruitment in Osteoporosis Therapy
Not yet reported Johns Hopkins University 55 participants Est. completion 2020-08-07 1 siteOther conditions: Low Bone DensityView official trial listing → -
Completed NCT NCT01657162
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
Not yet reported Radius Health, Inc. 1139 participants Est. completion 2016-10-03 25 sites Stand-aloneOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT01750086
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Not yet reported Massachusetts General Hospital 27 participants Est. completion 2014-08 1 siteOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT01770106
RA Denosumab on Bone Microstructure Study
Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2014-06 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01812551
Treatment of Low Bone Density in Cystic Fibrosis.
Not yet reported Istituto Auxologico Italiano 171 participants Est. completion 2007-07 11 sitesOther conditions: Osteoporosis, Cystic FibrosisView official trial listing → -
Completed NCT NCT01875458
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
University of Pennsylvania 314 participants Est. completion 2022-10-30 1 siteOther conditions: Osteoporosis, With or Without Treatment, Bisphosphonate Treatment, Atypical Femur Fracture, Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ), Healthy VolunteersView official trial listing → -
Completed NCT NCT01882400
Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
Not yet reported Gilles Boire 11 participants Est. completion 2007-09 1 siteOther conditions: Osteoporosis, Muscular Dystrophy, Cystic FibrosisView official trial listing → -
Completed NCT NCT01889134
OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism
Not yet reported Wroclaw Medical University 112 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Primary HyperparathyroidismView official trial listing → -
Completed NCT NCT01968850
Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Not yet reported Unity Health Toronto 30 participants Est. completion 2018-03-19 2 sites Stand-aloneOther conditions: HIVView official trial listing → -
Completed NCT NCT02057263
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Not yet reported Massachusetts General Hospital 28 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Hepatitis BView official trial listing → -
Completed NCT NCT02132026
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
Not yet reported University of Edinburgh 152 participants Est. completion 2019-11-28 1 siteOther conditions: Calcific Aortic StenosisView official trial listing → -
Completed NCT NCT02139007
Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study
Not yet reported University of Alabama at Birmingham 27 participants Est. completion 2016-07 1 siteOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT02166437
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
Tomidahama Hospital 500 participants Est. completion 2018-11 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02168543
1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers
Not yet reported Government Dental College and Research Institute, Bangalore 46 participants Est. completion 2011-04 Stand-aloneOther conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02195895
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
Not yet reported Northwestern University 17 participants Est. completion 2016-08-05 1 site Stand-aloneOther conditions: Spinal Cord Injury, Bone Loss, OsteoporosisView official trial listing → -
Completed NCT NCT02230332
Alendronate to Prevent Loss of Bronchoprotection in Asthma
Not yet reported, Not yet reported Milton S. Hershey Medical Center 78 participants Est. completion 2016-09 10 sites Stand-aloneOther conditions: AsthmaView official trial listing → -
Completed NCT NCT02303873
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta
Not yet reported Peking Union Medical College Hospital 99 participants Est. completion 2014-08 Stand-aloneOther conditions: Osteogenesis ImperfectaView official trial listing → -
Completed NCT NCT02304757
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142 participants Est. completion 2019-12-30 1 siteOther conditions: Differentiated Thyroid Cancer, OsteoporosisView official trial listing → -
Terminated NCT NCT02322099
Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss
Not yet reported University College Dublin 53 participants Est. completion 2019-09 2 sitesOther conditions: Bone DemineralizationView official trial listing → -
Completed NCT NCT02371252
Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment
Not yet reported Mahidol University 140 participants Est. completion 2016-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02416271
The Forteo Alendronate Comparator Trial
Not yet reported Eli Lilly and Company 203 participants Est. completion 2003-05 20 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02417389
Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
Not yet reported Istituto Auxologico Italiano 22 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: Hyperparathyroidism, Primary, OsteoporosisView official trial listing → -
Completed NCT NCT02440581
Renal Osteodystrophy: An Individual Management Approach
Not yet reported Hartmut Malluche, MD 141 participants Est. completion 2021-06-30 1 site Stand-aloneOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT02445664
Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment
Not yet reported University of Southern Denmark 67 participants Est. completion 2014-11 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02455869
Comparison of Alendronate With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 104 participants Est. completion 2015-03Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02461667
Alendronate Compared to Metformin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 108 participants Est. completion 2015-03Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02470611
Sodium Alendronate in Non Surgical Periodontal Therapy
Not yet reported Federal University of Minas Gerais 32 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Periodontitis, Bone ResorptionView official trial listing → -
Completed NCT NCT02516111
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2015-05Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02518152
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2015-06 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02520362
Denosumab Safety Assessment in Multiple Observational Databases
Amgen 517991 participants Est. completion 2023-07-21Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02598440
A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
Not yet reported Hoffmann-La Roche 341 participants Est. completion 2005-05 54 sites Stand-aloneOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT02598453
PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
Not yet reported Hoffmann-La Roche 545 participants Est. completion 2006-09 60 sitesOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT02604836
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
Not yet reported Hoffmann-La Roche 1711 participants Est. completion 2006-04 142 sitesOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT02609061
Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 72 participants Est. completion 2015-09 1 siteOther conditions: Furcation DefectsView official trial listing → -
Status unknown NCT NCT02645799
BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY
Not yet reported BIOrest Ltd. 270 participants Est. completion 2018-11 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02731040
Exome Sequencing for Atypical Femoral Fractures
Washington University School of Medicine 38 participants Est. completion 2018-03-29Other conditions: Atypical Femoral Fractures, Osteoporosis, Bisphosphonate TherapyView official trial listing → -
Terminated NCT NCT02781805
Pilot Study of Bisphosphonates for Breast Cancer
Not yet reported University of Wisconsin, Madison 6 participants Est. completion 2018-12-12 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02795546
Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.
Not yet reported Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 32 participants Est. completion 2016-04 Stand-aloneOther conditions: Intrabony Periodontal DefectView official trial listing → -
Completed NCT NCT02944799
Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
Not yet reported University of Aarhus 69 participants Est. completion 2021-12-20 6 sitesOther conditions: Rheumatoid Arthritis, OsteoporosisView official trial listing → -
Completed NCT NCT03005678
Denosumab Versus Bisphosphonates (Alendronate) in GIOP
Not yet reported Tuen Mun Hospital 140 participants Est. completion 2020-02-01 1 siteOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT03006003
Osteoporosis Treatment in Post-menopausal Women
Not yet reported Taichung Veterans General Hospital 500 participants Est. completion 2021-12 2 sitesOther conditions: Depressive SyndromeView official trial listing → -
Status unknown NCT NCT03040531
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis
Not yet reported, Not yet reported University of Messina 200 participants Est. completion 2018-12-30 2 sitesOther conditions: Osteoporosis, Steroid InducedView official trial listing → -
Completed NCT NCT03051620
Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate
Aarhus University Hospital 142 participants Est. completion 2019-01-31 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT03197623
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
Not yet reported Nancy E. Lane, MD 58 participants Est. completion 2021-03-31 4 sites Stand-aloneOther conditions: Osteopenia, Osteoporosis, OsteonecrosisView official trial listing → -
Completed NCT NCT03204097
Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2017-02Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT03292146
Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
Not yet reported Massachusetts General Hospital 30 participants Est. completion 2021-07-22 1 site Stand-aloneObstructive sleep apnea Other conditions: Bone Density, Bone Loss, Eating DisorderView official trial listing → -
Completed NCT NCT03396315
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
Not yet reported Columbia University 24 participants Est. completion 2023-06-09 2 sitesOther conditions: IOP, OsteoporosisView official trial listing → -
Status unknown NCT NCT03435094
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Labatec Pharma SA 80 participants Est. completion 2022-12-01 2 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT03542695
64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy
Not yet reported City of Hope Medical Center 1 participants Est. completion 2024-05-31 1 site Stand-aloneOther conditions: Breast Carcinoma, CalcificationView official trial listing → -
Active, not recruiting NCT NCT03623633
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Not yet reported Massachusetts General Hospital 51 participants Est. completion 2023-08-01 1 siteOther conditions: Osteoporosis, Postmenopausal, OsteoporosisView official trial listing → -
Active, not recruiting NCT NCT03692143
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP
Nanfang Hospital, Southern Medical University 90 participants Est. completion 2030-12-01Other conditions: Osteoporosis, Postmenopausal, Vertebral Fracture, Quality of LifeView official trial listing → -
Completed NCT NCT03980847
Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket
Not yet reported Islamic Azad University, Sanandaj 20 participants Est. completion 2019-04-25 1 siteOther conditions: Bone ResorptionView official trial listing → -
Status unknown NCT NCT04140006
Efficacy of Antiresorptive and Bone Forming Material on Dental Implants
Not yet reported, Not yet reported University of Baghdad 20 participants Est. completion 2020-07-01 1 siteOther conditions: Partial EdentulismView official trial listing → -
Completed NCT NCT04169698
Alendronate Versus Denosumab in Kidney Transplant Patients
Not yet reported, Not yet reported Ain Shams University 90 participants Est. completion 2021-05-01 1 site Stand-aloneOther conditions: Osteoporosis, Osteopenia, Renal Transplant RecipientView official trial listing → -
Completed NCT NCT04177940
Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study
Not yet reported University of Alabama at Birmingham 45 participants Est. completion 2025-01-14 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT04338529
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
251 Hellenic Air Force & VA General Hospital 92 participants Est. completion 2024-11-01 1 siteOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Completed NCT NCT04403698
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
Not yet reported University Hospital, Ghent 30 participants Est. completion 2022-03-09 1 site Stand-aloneOsteoarthritisView official trial listing → -
Status unknown NCT NCT04555317
Bone Toxicity Following Pelvic Radiotherapy
Not yet reported The Christie NHS Foundation Trust 80 participants Est. completion 2025-08 1 siteOther conditions: Gynecologic Cancer, Radiotherapy Side Effect, FractureView official trial listing → -
Completed NCT NCT04708886
Romosozumab in Women With Chronic SCI
Not yet reported Northwestern University 12 participants Est. completion 2024-06-10 1 site Stand-aloneOther conditions: Osteoporosis, Bone Loss, Osteopenia, Osteoporosis, Spinal Cord Injuries, Chronic Spinal ParalysisView official trial listing → -
Status unknown NCT NCT04719572
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
Not yet reported Chinese PLA General Hospital 180 participants Est. completion 2023-01 1 siteOther conditions: Osteoporosis, Osteopenia, OsteoporosisView official trial listing → -
Status unknown NCT NCT04739592
A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis
Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2024-07 3 sites Stand-aloneOsteoarthritisView official trial listing → -
Status unknown NCT NCT04861142
Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy
University General Hospital of Heraklion 350 participants Est. completion 2024-10 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT05091099
The Optimal Sequential Therapy After Long Term Denosumab Treatment
Not yet reported National Taiwan University Hospital 44 participants Est. completion 2025-11-14 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Active, not recruiting NCT NCT05151484
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Not yet reported Madhumathi Rao 60 participants Est. completion 2027-01-31 1 siteOther conditions: Age-Related OsteoporosisView official trial listing → -
Status unknown NCT NCT05162885
Effect of Sodium Alendronate on the Final Implant Stability.
Not yet reported Cairo University 24 participants Est. completion 2022-10-01 1 siteOther conditions: Anterior Labial Wall DefectView official trial listing → -
Status unknown NCT NCT05305183
A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
Not yet reported Shandong New Time Pharmaceutical Co., LTD 330 participants Est. completion 2024-05-31 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT05325515
The Effect of Effervescent Alendronate on Bone Turnover
Not yet reported Aarhus University Hospital 64 participants Est. completion 2022-12-01 1 site Stand-aloneOther conditions: Osteopenia or OsteoporosisView official trial listing → -
Completed NCT NCT05366621
Post-fracture Medication and Mortality
National Cheng-Kung University Hospital 216155 participants Est. completion 2021-10-31 1 siteOther conditions: Osteoporosis, Osteoporosis Fracture, Drug Therapy, Mortality, Adherence, MedicationView official trial listing → -
Status unknown NCT NCT05387200
Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
Not yet reported Yonsei University 170 participants Est. completion 2023-05 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT05397938
Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis
Not yet reported Shanghai JMT-Bio Inc. 231 participants Est. completion 2023-06-01 1 site Stand-aloneOther conditions: Glucocorticoid Induced OsteoporosisView official trial listing → -
Completed NCT NCT05493761
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
Not yet reported Aristotle University Of Thessaloniki 72 participants Est. completion 2026-07-16 3 sitesOther conditions: Nonalcoholic Fatty Liver, Osteoporosis, PostmenopausalView official trial listing → -
Active, not recruiting NCT NCT05575167
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
424 General Military Hospital 122 participants Est. completion 2027-11 9 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Status unknown NCT NCT05602493
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
Not yet reported Xeolas Pharmaceuticals Limited 60 participants Est. completion 2024-10-20 1 siteOther conditions: Bone Loss, AlveolarView official trial listing → -
Status unknown NCT NCT05645289
Efficacy and Safety of Minodronate in Patients With Low Back Pain
Not yet reported Peking University Third Hospital 72 participants Est. completion 2024-04-01 1 siteOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Status unknown NCT NCT05662358
Denosumab vs Alendronate After Vertebroplasty
Not yet reported Shenzhen People's Hospital 90 participants Est. completion 2023-10-25 1 siteOther conditions: Denosumab AllergyView official trial listing → -
Status unknown NCT NCT05771038
Assessment of Bone Quality After Socket Preservation Using Sodium Alendronate Gel Compared to Sticky Bone
Not yet reported Cairo University 32 participants Est. completion 2023-07 1 siteOther conditions: Bone Quality Assessment, Preserved Sockets, Sodium Alendronate, Sticky BoneView official trial listing → -
Completed NCT NCT06264401
Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis
Not yet reported Cairo University 60 participants Est. completion 2024-06-02 1 site Stand-aloneOther conditions: Postmenopausal OsteoporosisView official trial listing → -
Enrolling by invitation NCT NCT06264609
Precision Medicine Approach for Osteoporosis - Follow Up Study
Not yet reported Paul F Netzel 40 participants Est. completion 2029-12-31 1 site Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT06621069
The Effect of Long-term Use of Bisphosphonates on Femur Morphology
Second Affiliated Hospital, Zhejiang University, School of Medicine 140 participants Est. completion 2024-08-01 1 siteOther conditions: Osteoporosis, Knee OsteoarthristisView official trial listing → -
Completed NCT NCT06772792
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)
Not yet reported Merck Sharp & Dohme LLC 36 participants Est. completion 2024-06-21 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT06856369
Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis
Not yet reported Bahria University 120 participants Est. completion 2027-09-30 1 siteOther conditions: Alveolar Bone Loss Associated Chronic PeriodontitisView official trial listing → -
Withdrawn NCT NCT06973109
Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes
Not yet reported University of Pittsburgh Est. completion 2027-06 1 site Stand-aloneOther conditions: Osteoporosis, Post-menopausalView official trial listing → -
Completed NCT NCT07028320
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 493 participants Est. completion 2024-05-20 1 siteOther conditions: Postmenopausal Women With OsteoporosisView official trial listing → -
Completed NCT NCT07242612
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Not yet reported Khyber Medical University Peshawar 40 participants Est. completion 2026-04-15 1 siteOther conditions: Osteoporosis, Osteoporosis, PostmenopausalView official trial listing → -
Not yet recruiting NCT NCT07245381
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Not yet reported, Not yet reported Dr. Itay GoorAryeh 65 participants Est. completion 2026-09 Stand-aloneOther conditions: Cervix CancerView official trial listing → -
Active, not recruiting NCT NCT07471880
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Not yet reported ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 161 participants Est. completion 2027-02-28 1 siteOther conditions: Osteonecrosis, Osteonecrosis of the Femoral HeadView official trial listing → -
Enrolling by invitation NCT NCT07652372
Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis
Not yet reported ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 60 participants Est. completion 2027-09-30 2 sitesOsteoarthritisView official trial listing → -
Completed NCT NCT07717788
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Osteoporosis, Postmenopausal, Statin TherapyView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Alendronate Sodium, Alendronate, Alendronate 70mg weekly
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
